{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:07:51Z","timestamp":1765886871636},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,1]]},"DOI":"10.1373\/clinchem.2005.049700","type":"journal-article","created":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T23:29:07Z","timestamp":1124926147000},"page":"1735-1738","source":"Crossref","is-referenced-by-count":18,"title":["Effects of 4 Weeks of Atorvastatin Administration on the Antiinflammatory Cytokine Interleukin-10 in Patients with Unstable Angina"],"prefix":"10.1093","volume":"51","author":[{"given":"Jian-Jun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hong","family":"Fang","sequence":"first","affiliation":[{"name":"Renmin Hospital, Wuhan University School of Medicine, Wuhan, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,9,1]]},"reference":[{"key":"2020022800453143100_R1","doi-asserted-by":"crossref","unstructured":"Maseri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med1997;336:1014-1016.","DOI":"10.1056\/NEJM199704033361409"},{"key":"2020022800453143100_R2","doi-asserted-by":"crossref","unstructured":"Ross R. Atherosclerosis\u2014an inflammatory disease. N Engl J Med1993;340:115-126.","DOI":"10.1056\/NEJM199901143400207"},{"key":"2020022800453143100_R3","doi-asserted-by":"crossref","unstructured":"Libby P, Ridker PM. Novel inflammatory markers of coronary risk: theory versus practice. Circulation1999;100:1148-1150.","DOI":"10.1161\/01.CIR.100.11.1148"},{"key":"2020022800453143100_R4","doi-asserted-by":"crossref","unstructured":"Li J-J, Fang C-H. C-Reactive protein is not only a marker but also direct cause of cardiovascular disease. Med Hypotheses2004;62:499-506.","DOI":"10.1016\/j.mehy.2003.12.014"},{"key":"2020022800453143100_R5","doi-asserted-by":"crossref","unstructured":"Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med1994;331:417-424.","DOI":"10.1056\/NEJM199408183310701"},{"key":"2020022800453143100_R6","doi-asserted-by":"crossref","unstructured":"Morrow DA, Rifai N, Antman EM. C-Reactive protein is a potent predicator of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol1998;31:1460-1465.","DOI":"10.1016\/S0735-1097(98)00136-3"},{"key":"2020022800453143100_R7","doi-asserted-by":"crossref","unstructured":"Li J-J, Wang H-R, Huang C-X, Xue J-L, Li G-S. Enhanced response of blood monocytes to C-reactive protein in patients with unstable angina. Clin Chim Acta2005;352:127-133.","DOI":"10.1016\/j.cccn.2004.08.019"},{"key":"2020022800453143100_R8","doi-asserted-by":"crossref","unstructured":"Smith DA, Irving SD, Sheldon J, Kaski JC. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation2001;104:746-750.","DOI":"10.1161\/hc3201.094973"},{"key":"2020022800453143100_R9","doi-asserted-by":"crossref","unstructured":"Alam SE, Nasser SS, Fernainy KE, Habib AA, Badr KF. Cytokine imbalance in acute coronary syndrome. Curr Opin Pharmacol2004;4:166-170.","DOI":"10.1016\/j.coph.2003.10.011"},{"key":"2020022800453143100_R10","doi-asserted-by":"crossref","unstructured":"Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation2003;107:2109-2114.","DOI":"10.1161\/01.CIR.0000065232.57371.25"},{"key":"2020022800453143100_R11","doi-asserted-by":"crossref","unstructured":"Mizia-Stec K, Gasior Z, Zahorska-Markiewiez B, Janowska J, Szulc A, Jastrzebska-Maj E, et al. Serum tumor necrosis factor-\u03b1, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes. Coron Artery Dis2003;14:431-438.","DOI":"10.1097\/00019501-200309000-00003"},{"key":"2020022800453143100_R12","doi-asserted-by":"crossref","unstructured":"Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher A. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol2004;44:50-52.","DOI":"10.1016\/j.jacc.2004.02.054"},{"key":"2020022800453143100_R13","doi-asserted-by":"crossref","unstructured":"Schieffer B, Bunte C, Witte J, Hoeper K, Boger RH, Schwedhelm E, et al. Comparative effects of anti-antagonism and angiotensin converting enzyme inhibition on markers of inflammation, platelet aggregation in patients with coronary disease. J Am Coll Cardiol2004;44:362-368.","DOI":"10.1016\/j.jacc.2004.03.065"},{"key":"2020022800453143100_R14","doi-asserted-by":"crossref","unstructured":"Plenge JK, Hernandez TL, Weil KM, Poirier P, Grunwald GK, Marcovina SM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation2002;106:1447-1452.","DOI":"10.1161\/01.CIR.0000029743.68247.31"},{"key":"2020022800453143100_R15","doi-asserted-by":"crossref","unstructured":"Li J-J, Chen M-Z, Chen -X, Fang C-H.. Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Clin Cardiol2003;26:472-476.","DOI":"10.1002\/clc.4960261008"},{"key":"2020022800453143100_R16","doi-asserted-by":"crossref","unstructured":"Li J-J, Chen X-J. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide. Coron Artery Dis2003;14:329-334.","DOI":"10.1097\/01.mca.0000078062.22445.60"},{"key":"2020022800453143100_R17","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C-reactive with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation2001;103:1191-1193.","DOI":"10.1161\/01.CIR.103.9.1191"},{"key":"2020022800453143100_R18","doi-asserted-by":"crossref","unstructured":"Li J-J, Jiang H, Huang C-X, Fang C-H, Tang Q-Z, Xiao H, et al. Elevated levels of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile. Angiology2002;53:265-272.","DOI":"10.1177\/000331970205300303"},{"key":"2020022800453143100_R19","doi-asserted-by":"crossref","unstructured":"Li J-J, Fang C-H, Cheng M-Z, Cheng X. Activation of nuclear factor-\u03baB and correlation with elevated plasma C-reactive protein in patients with unstable angina. Heart Lung Circ2004;13:173-178.","DOI":"10.1016\/j.hlc.2004.02.005"},{"key":"2020022800453143100_R20","doi-asserted-by":"crossref","unstructured":"Davis MJ. Stability and unstability: the two faces of coronary atherosclerosis. Circulation1996;94:2013-2020.","DOI":"10.1161\/01.CIR.94.8.2013"},{"key":"2020022800453143100_R21","doi-asserted-by":"crossref","unstructured":"Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation1994;90:775-780.","DOI":"10.1161\/01.CIR.90.2.775"},{"key":"2020022800453143100_R22","doi-asserted-by":"crossref","unstructured":"Wang P, Wu P, Siegel MI, Egan RW, Billa MM. Interleukin (IL)-10 inhibits nuclear factor \u03baB (NF \u03baB) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem1995;270:9558-9563.","DOI":"10.1074\/jbc.270.16.9558"},{"key":"2020022800453143100_R23","doi-asserted-by":"crossref","unstructured":"Lacraz S, Nicod LP, Chicheortiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest1995;96:2304-2310.","DOI":"10.1172\/JCI118286"},{"key":"2020022800453143100_R24","doi-asserted-by":"crossref","unstructured":"Lindmark E, Tenno T, Chen J, Siegbahn A. IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood. Br J Haematol1998;102:597-604.","DOI":"10.1046\/j.1365-2141.1998.00808.x"},{"key":"2020022800453143100_R25","doi-asserted-by":"crossref","unstructured":"Arai T, Hiromatus K, Nishimura H, Kimura Y, Kobayashi N, Ishida H, et al. Endogenous interleukin 10 prevent apoptosis in macrophages during Salmonella infection. Biochem Biophys Res Commun1995;213:600-607.","DOI":"10.1006\/bbrc.1995.2174"},{"key":"2020022800453143100_R26","doi-asserted-by":"crossref","unstructured":"Pinderski LJ, Fishbein MP, Subbanagounder G, Fishbein MC, Kubo N, Cheroutre H, et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes. Circ Res2002;90:1064-1071.","DOI":"10.1161\/01.RES.0000018941.10726.FA"},{"key":"2020022800453143100_R27","doi-asserted-by":"crossref","unstructured":"Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med1995;332:481-487.","DOI":"10.1056\/NEJM199502233320801"},{"key":"2020022800453143100_R28","doi-asserted-by":"crossref","unstructured":"Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation1999;100:230-235.","DOI":"10.1161\/01.CIR.100.3.230"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/51\/9\/1735\/32682889\/clinchem1735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/51\/9\/1735\/32682889\/clinchem1735.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T05:47:08Z","timestamp":1582868828000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/51\/9\/1735\/5629915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2005,9,1]]},"published-print":{"date-parts":[[2005,9,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2005.049700","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,9,1]]},"published":{"date-parts":[[2005,9,1]]}}}